Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review

Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review

Background and Aim: Sitafloxacin-based therapy is a potent candidate for third-line <i>Helicobacter pylori</i> eradication treatment. In this systematic review, we summarise current reports with sitafloxacin-based therapy as a third-line treatment. Methods: Clinical studies were systemat...

Full description

Bibliographic Details
Main Authors:	Toshihiro Nishizawa, Munkhbayar Munkjargal, Hirotoshi Ebinuma, Osamu Toyoshima, Hidekazu Suzuki
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Journal of Clinical Medicine
Subjects:	sitafloxacin vonoprazan <i>H. pylori</i>
Online Access:	https://www.mdpi.com/2077-0383/10/12/2722

Similar Items

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
by: Soichiro Sue, et al.
Published: (2021-02-01)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
by: Yoshimasa Saito, et al.
Published: (2019-01-01)

Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
by: Yoshihiro Hirata, et al.
Published: (2016-10-01)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019-01-01)

The Potential Benefits of Vonoprazan as <i>Helicobacter pylori</i> Infection Therapy
by: Muhammad Miftahussurur, et al.
Published: (2020-09-01)

Vonoprazan-Associated Gastric Mucosal Redness in Non-Helicobacter pylori-Infected and Helicobacter pylori-Eradicated Stomach
by: Kimitoshi Kubo, et al.
Published: (2021-08-01)

Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
by: Amin Talebi Bezmin Abadi, et al.
Published: (2019-04-01)

Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan
by: Takano K, et al.
Published: (2021-07-01)

Optimization Strategies Aimed to Increase the Efficacy of <i>Helicobacter pylori</i> Eradication Therapies with Quinolones
by: Javier P. Gisbert
Published: (2020-11-01)

Best <i>Helicobacter pylori</i> Eradication Strategy in the Era of Antibiotic Resistance
by: Su Young Kim, et al.
Published: (2020-07-01)

The Association between Serum Vitamin D Levels and <i>Helicobacter pylori</i> Presence and Eradication
by: Asher Shafrir, et al.
Published: (2021-01-01)

Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01)

<i>Helicobacter pylori</i> eradication in nonulcer dyspepsia: Does it really matter?
by: AlMalki Ahmad
Published: (2008-01-01)

Effect of β-caryophyllene from Cloves Extract on <i>Helicobacter pylori</i> Eradication in Mouse Model
by: Da Hyun Jung, et al.
Published: (2020-04-01)

<i>Helicobacter pylori</i> Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and <i>H. pylori</i> Prevalence
by: Seung Joo Kang, et al.
Published: (2019-08-01)

Efficacy and Safety of Sitafloxacin in the Treatment of Acute Bacterial Infection: A Meta-analysis of Randomized Controlled Trials
by: Chao-Kun Chen, et al.
Published: (2020-03-01)

Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria
by: Guo, Y., et al.
Published: (2022)

Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial
by: Lojanapiwat B, et al.
Published: (2019-01-01)

Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis
by: Ryan P. Trombetta, et al.
Published: (2019-02-01)

Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for <i>Helicobacter pylori</i> Infection: Meta-Analysis of Randomized Controlled Studies
by: Dmitrii N. Andreev, et al.
Published: (2019-09-01)

Helicobacter pylori eradication improved the Kyoto classification score on endoscopy
by: Osamu Toyoshima, et al.
Published: (2020-10-01)

Current <i>Helicobacter pylori</i> Diagnostics
by: Dmitry S. Bordin, et al.
Published: (2021-08-01)

Rifabutin for the Treatment of <i>Helicobacter Pylori</i> Infection: A Review
by: Javier P. Gisbert
Published: (2021-12-01)

<i>Helicobacter pylori</i> Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance
by: Seung In Seo, et al.
Published: (2019-12-01)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial
by: Ira N. Kalfus, et al.
Published: (2020-10-01)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of <i>Helicobacter pylori</i>?
by: Young Min Kim, et al.
Published: (2020-09-01)

Efficacy of Low Dose Proton Pump Inhibitor-Based Therapy to Eradicate <i>Helicobacter pylori</i> in Patients with Subtotal Gastrectomy
by: Dongwoo Kim, et al.
Published: (2019-11-01)

Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of <i>Helicobacter pylori</i> Infection
by: Nikola Perkovic, et al.
Published: (2021-06-01)

Evaluation of the Effectiveness of <i>Helicobacter pylori</i> Eradication Regimens in Lithuania during the Years 2013–2020: Data from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
by: Paulius Jonaitis, et al.
Published: (2021-06-01)

Impact of Different <i>Helicobacter pylori</i> Eradication Therapies on Gastrointestinal Symptoms
by: Antonio Mestrovic, et al.
Published: (2021-08-01)

Evodiamine Inhibits <i>Helicobacter pylori</i> Growth and <i>Helicobacter pylori</i>-Induced Inflammation
by: Ji Yeong Yang, et al.
Published: (2021-03-01)

The Reduction in Gastric Atrophy after <i>Helicobacter pylori</i> Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion
by: Ryota Niikura, et al.
Published: (2019-04-01)

Risk of Reflux-Related Symptoms and Reflux Esophagitis after <i>Helicobacter pylori</i> Eradication Treatment in the Japanese Population
by: Mitsushige Sugimoto, et al.
Published: (2021-04-01)

The Effects of Sulglycotide on the Adhesion and the Inflammation of <i>Helicobacter Pylori</i>
by: Ji Yeong Yang, et al.
Published: (2020-04-01)

Efficacy of <i>Helicobacter pylori</i> eradication therapy of infection with omeprazole and rabeprazole in overweight and obese patients
by: D. T. Dicheva, et al.
Published: (2020-05-01)

Nutrient Deficiency Promotes the Entry of <i>Helicobacter pylori</i> Cells into <i>Candida</i> Yeast Cells
by: Kimberly Sánchez-Alonzo, et al.
Published: (2021-05-01)

Endoscopic Reflux Esophagitis and Reflux-Related Symptoms after <i>Helicobacter pylori</i> Eradication Therapy: Meta-Analysis
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

The Role of Statins on <em>Helicobacter pylori</em> Eradication: Results from the European Registry on the Management of <em>H. pylori</em> (Hp-EuReg)
by: María Caldas, et al.
Published: (2021-08-01)

Genetics of Host Protection against <i>Helicobacter pylori</i> Infections
by: Rosanna Capparelli, et al.
Published: (2021-03-01)